AGUZZI, CAROLA
 Distribuzione geografica
Continente #
NA - Nord America 800
EU - Europa 697
AS - Asia 348
SA - Sud America 1
Totale 1.846
Nazione #
US - Stati Uniti d'America 791
CN - Cina 343
IE - Irlanda 180
DE - Germania 139
UA - Ucraina 121
GB - Regno Unito 74
FI - Finlandia 69
SE - Svezia 40
IT - Italia 37
BE - Belgio 13
FR - Francia 12
MX - Messico 9
ES - Italia 3
IN - India 3
RU - Federazione Russa 3
CZ - Repubblica Ceca 2
GR - Grecia 2
NL - Olanda 2
BR - Brasile 1
LK - Sri Lanka 1
MY - Malesia 1
Totale 1.846
Città #
Chandler 222
Dublin 180
Jacksonville 141
Nanjing 109
Ashburn 61
Beijing 56
Ann Arbor 55
Nanchang 40
Wilmington 30
Lawrence 29
Medford 29
Princeton 29
Shenyang 29
Hangzhou 22
Helsinki 21
Jiaxing 19
Changsha 18
Boardman 17
Hebei 17
Brussels 13
Woodbridge 12
Shanghai 11
New York 10
Pavia 10
Tianjin 10
Cuauhtémoc 6
Norwalk 6
Milan 5
Verona 5
Fairfield 4
Auburn Hills 3
Houston 3
Los Angeles 3
Cambridge 2
Des Moines 2
Gunzenhausen 2
Kunming 2
Lanskroun 2
Madrid 2
Monterrey 2
Ningbo 2
Porto Empedocle 2
Washington 2
Bologna 1
Colombo 1
Columbus 1
Dearborn 1
Fiumefreddo Di Sicilia 1
Fuzhou 1
Guangzhou 1
Haikou 1
Huizen 1
Indore 1
Kemerovo 1
Kuala Lumpur 1
Leawood 1
Menlo Park 1
Natal 1
Nuremberg 1
Parma 1
Pune 1
Rome 1
Seattle 1
Selargius 1
Sezze 1
Taizhou 1
Torrent 1
Venezia 1
Totale 1.270
Nome #
Development of new controlled release systems based on mineral supports:I.Sorption behaviour of tetracyclines onto a pharmaceutical grade silicate 101
Desarrollo de una formulación bioadhesiva de liberación controlada para su administración periodontal. 88
IR study of doxycycline-silicate interaction 83
Control of tetracyclines delivery by their interaction with Veegum 81
Influence of dispersion conditions of two pharmaceutical grade clays on their interaction with some tetracyclines 80
Carvacrol/clay hybrids loaded into in situ gelling films 77
Influence of complex solubility on formulations based on lambda carrageenan and basic drugs 76
Novel controlled release formulations based on tetracycline-clay interaction products for periodontal administration 76
Study of adsorption kineticsof 5-aminosalicilyc acid in phyllosilicates for controlled drugdelivery in the treatment of inflammatory bowel disease. 73
Penetration and distribution of thiocolchicoside through human skin. Comparison between a commercial foam (Miotens®) and a drug solution 73
Development of new controlled release systems based on mineral support: III: Release studies of Tetracyclines-silicate interaction products 71
Prodotti di interazione tra lambda-carragenano e farmaci basici. Influenza della granulometria e del contenuto di umidità 71
Montmorillonite and chitosan nano composite for the delivery of silver sulfadiazine in infected wounds 71
Lambda carrageenan and basic drug complexes: employment in oral controlled release tablet formulation 69
Stato di aggregazione e capacità di interazione di argille impiegate in formulazioni a rilascio controllato 66
Behaviour upon hydration of drug-polymer complexes of different solubility: influence on CR tablet performance 65
Penetration and distribution of thiocolchicoside through human skin: comparison between a commercial foam (Miotens®) and a drug solution 63
Solid-state characterization of lambda carrageenan-basic drug interaction product 62
Employment of lambda carrageenan complexes in controlled release tablet formulations 62
Influenza della solubilità di complessi carragenano farmaci basici in formulazioni orali a rilascio controllato 62
Relationship between aggregation degree and adsorption capacities of some clays used in controlled release formulations 61
Influence of complex solubility on formulations based on lambda carragenan and basic drugs 59
Development of polymers/hybrids films for the delivery of Eos. 49
The added value of nanotechnology to wound healing 42
Montmorillonite-norfloxacin nanocomposite intended for healing of infected wounds 40
Norfloxacin-loaded electrospun scaffolds: Montmorillonite nanocomposite vs. free drug 36
Halloysite-and montmorillonite-loaded scaffolds as enhancers of chronic wound healing 36
Solid state characterisation of silver sulfadiazine loaded on montmorillonite/chitosan nanocomposite for wound healing 34
Polyelectrolyte-drug complexes of lambda carrageenan and basic drugs: relevance of particle size and moisture content on compaction and drug release behaviour 32
Natural and Synthetic Clay Minerals in the Pharmaceutical and Biomedical Fields 10
Characterization and Molecular Modelling of Non-Antibiotic Nanohybrids for Wound Healing Purposes 8
Human lactoferrin-clay mineral nanohybrids as emerging green biomaterials: A physicochemical characterization 1
Totale 1.878
Categoria #
all - tutte 5.324
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.324


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 1 0 3
2019/2020441 112 156 5 22 1 26 4 24 4 61 18 8
2020/2021251 26 21 9 50 5 28 5 34 6 33 28 6
2021/2022159 3 2 1 7 1 4 5 7 7 6 23 93
2022/2023534 51 51 9 69 64 36 0 25 206 2 16 5
2023/2024160 17 31 7 12 22 37 19 8 3 4 0 0
Totale 1.878